Written by The Blood Group Typing Market is gaining importance as healthcare systems strengthen laboratory testing procedures associated with blood transfusion and transplantation. Accurate identification of ABO and Rh blood groups helps support compatible transfusion practices, while advanced typing methods can provide extended antigen information for patients with complex transfusion requirements. The market is forecast to reach USD 5.31 billion by 2035 from USD 2.41 billion in 2025.
Automation is becoming an important part of modern blood-bank workflows. Automated platforms can reduce manual intervention and support consistent testing processes, while molecular technologies are increasingly used when conventional serological methods cannot fully resolve complex antigen profiles. These developments are particularly relevant for patients receiving long-term transfusion support.
Services are projected to be the fastest-growing product category, with an estimated 11.1% CAGR through 2035. Molecular and next-generation sequencing approaches are also expected to expand as laboratories adopt extended genotyping. Antigen typing is forecast to grow at 12.3% CAGR, while diagnostic laboratories and other end users are expected to record 14.3% CAGR during the forecast period.
Regional development is supported by different healthcare priorities. North America benefits from established regulatory and transfusion infrastructure, Europe is adapting to evolving IVD requirements, and Asia-Pacific is expanding through government blood-safety initiatives. Point-of-care blood typing and AI-integrated image interpretation represent additional opportunities for future market development.
Explore key developments shaping industry transformation:
Neuropathic Pain Market Volume
Neuropathic Pain Market Forecast
Neuropathic Pain Market Outlook